Concepedia
Statistics
Publications
17
Citations
8.8K
H-Index
Active since
1999
Affiliations
Brown University(Current)
Université Paris Cité
Eli Lilly (United States)
Vanderbilt University
Rhode Island Hospital
Steven P. LaRosa is an author at Brown University specializing in sepsis, sepsis pharmacotherapy, and sepsis management.
Publications per year
1999–2021
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Gordon R. Bernard, Jean‐Louis Vincent, Pierre‐François Laterre et al. · New England Journal of Medicine · 2001 · 6.1K citations · Full text
Medicine, Pharmacology, Pharmacotherapy +13
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
Steven M. Opal, Pierre‐François Laterre, Bruno François et al. · JAMA · 2013 · 795 citations · Full text
Veterinary Medicine, Pharmacology, Pharmacotherapy +11
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*
Jean‐Louis Vincent, M Ramesh, David Ernest et al. · Critical Care Medicine · 2013 · 322 citations
Medicine, Pharmacology, Pharmacotherapy +15
Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials*
Sachin Yende, Shamly Austin, Andrew Rhodes et al. · Critical Care Medicine · 2016 · 278 citations · Full text
Veterinary Medicine, Internal Medicine, Palliative Care +11
Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*
Mark Tidswell, William Tillis, Steven P. LaRosa et al. · Critical Care Medicine · 2009 · 226 citations
Medicine, Immunology, Pharmacology +17
1–5 of 17